Centene price target raised to $80 from $70 at Cantor Cantor increased its price target on Centene after the company reported higher than expected Q1 EPS and raised its guidance. The firm keeps a Buy rating on the shares.
Centene appoint Ken Yamaguchi to EVP and Chief Medical Officer Centene announced the appointment of Ken Yamaguchi to Executive Vice President and Chief Medical Officer, effective immediately. Yamaguchi currently is the Sam & Marilyn Fox Distinguished Professor of Orthopaedic Surgery at Washington University and will continue in that role as part-time faculty. Centene also announced the appointment of Mary Mason to Senior Vice President and Chief Medical Officer of Specialty Companies.